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Abstract 
Aortic pulse wave velocity (PWV) and backward waves, as determined from wave 
separation analysis, predict cardiovascular events beyond brachial blood pressure (BP). 
However, the extent to which these aortic hemodynamic variables contribute independent of 
each other is uncertain. In 749 randomly selected participants of African ancestry we therefore 
assessed the extent to which relationships between aortic PWV or backward wave pressures 
(Pb)(and hence central aortic pulse pressure [PPc]) and left ventricular mass index (LVMI) occur 
independent of each other. Aortic PWV, PPc, forward wave pressure (Pf) and Pb were 
determined using radial applanation tonometry and SphygmoCor software and LVMI using 
echocardiography. 44.5% of participants had an increased LVMI-ht1.7. With adjustments for age, 
brachial systolic BP or PP and additional confounders, PPc and Pb, but not Pf was 
independently related to LVMI and LV hypertrophy (LVH) in both men and women. However, 
PWV was independently associated with LVMI in women (partial r=0.16, p<0.001), but not in 
men (partial r=0.03) and PWV was independently associated with LVH in women (p<0.05), but 
not in men (p=0.07). With PWV and Pb included in the same multivariate regression models, 
PWV (partial r=0.14, p<0.005) and Pb (partial r=0.10, p<0.05) contributed to a similar extent to 
variations in LVMI in women. In addition, with PWV and Pb included in the same multivariate 
regression models, PWV (p<0.05) and Pb (p<0.02) contributed to LVH in women. In conclusion, 
aortic PWV and backward wave pressure (and hence pulse pressure) although both associated 
with LVMI and LVH, produce effects which are independent of each other. 
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Preface. 
Cardiovascular disease (CVD) has reached epidemic proportions globally. In Sub 
Saharan Africa, including South Africa, the mortality could be as high as 350/100,000 
population. Hypertension is one of the leading causes of CVD, and is often associated with an 
increase in large artery stiffness, as indexed using the easy to measure carotid-femoral (aortic) 
pulse wave velocity (PWV). Aortic PWV predicts stroke, and myocardial infarction, beyond 
conventional cardiovascular risk factors, including brachial blood pressure. It is estimated that 
an increase in aortic PWV by 1 m/s corresponds to a 14-15% increased risk of a cardiovascular 
event beyond conventional risk factors. However, the exact mechanisms responsible for the 
ability of aortic PWV to predict cardiovascular events is still uncertain. 
 In the present dissertation, I aimed at evaluating the contribution of aortic haemodynamics to 
brachial BP-independent relations between PWV and LVMI in a community sample of black 
African ancestry. In the first chapter, I review the current evidence for a role of aortic PWV and 
other haemodynamic factors to mediating cardiovascular damage. In this same chapter I argue 
in favor of performing the study conducted. In chapter 2, I describe the methodology employed 
to perform the present study, and include a description of participant recruitment, and the 
methods for assessing aortic PWV, aortic blood pressure and left ventricular mass as well as 
the approaches that I employed for data analysis. In chapter 3, I describe the results of the 
study, and finally in chapter 4, I discuss my data in the context of existing literature on this topic 
and pose potential clinical implications as well as highlight the limitations of the study. 
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Chapter 1 
 
Aortic stiffness: Current understanding of the contribution  
                     to cardiovascular disease. 
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1.1 Introduction 
 
Cardiovascular disease (CVD) is a broad term that refers to several disorders of the 
heart and vessels which have a common aetiology. These disorders include cerebrovascular 
accidents or stroke, heart failure, myocardial infarction, peripheral arterial disease, and renal 
failure. All of these disorders contribute significantly to morbidity and mortality. Globally, it is 
estimated that approximately 8 million premature deaths occur per year that can be attributed to 
CVD (WHO, 2017, Lozano et al., 2013, and Cappuccio and Miller, 2016), and CVD is one of the 
leading causes of death in developing countries, including Africa (Boutayeb, 2006;  Ebrahim and 
Smith, 2001; Kahn et al., 2000; Reddy, 2002). It is imperative, to accurately predict and hence 
prevent the occurrence of CVD, and in this regard several modifiable and non-modifiable risk 
factors associate with CVD, such as high blood pressure (BP) (hypertension), high plasma low 
density lipoprotein (LDL) cholesterol concentrations, low plasma high density lipoprotein (HDL) 
cholesterol concentrations, diabetes mellitus, smoking, male gender, and advancing age.  
 It is well recognized that hypertension is one of the most important risk factors for CVD. 
Worldwide, hypertension contributes to about 50% of stroke and heart failure (Campbell et al., 
2016). In developing countries, hypertension is the leading cause of heart failure and coronary 
artery disease (Irazola et al., 2016), as well as stroke (Akpalu et al., 2015; Connor et al., 2009; 
Mensah, 2008). Within the last 10 years, the risk of death from hypertension has increased by 
over 25% (Ibrahim and Damasceno, 2012). In South Africa, hypertension affects nearly a 
quarter of the entire population (Steyn et al., 2008). However, in urban settings this could be as 
high as 50% (Malhotra et al., 2008; Maseko et al., 2011). There is substantial evidence that 
antihypertensive therapy reduces the risk of cardiovascular events (Clarke et al., 2002). 
However, there is ongoing debate as to whom should receive therapy. In this regard, a 
continuous relationship exists between blood pressure (BP) and CVD, from BP values as low as 
120/80 mmHg (Chobanian et al., 2003; Vasan et al., 2001), and more recently evidence is 
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beginning to emerge that treating those to BP values well below currently accepted thresholds 
for treatment (140/90 mm Hg), that is to achieve target BP values of less than 120/80 mm Hg, 
further reduces cardiovascular events (SPRINT Study, 2015). However, it may not be cost-
effective to initiate therapy in persons with a BP below 140/90 mmHg. Hence there is a need to 
identify those at risk with BP values which would not traditionally be considered to require 
therapy. Although traditional risk factors including an increased BP measured at the brachial 
artery are well established causes of CVD (Menotti et al., 2009), epidemiological studies have 
shown that these risk factors do not necessarily always account for all cardiovascular events 
(Harald et al., 2008). Importantly, Individuals on medical therapy for a particular risk factor may 
sometimes have a worse cardiovascular outcome (Kohro et al., 2008; Szecsenyi et al., 2008). 
Therefore, risk assessment using traditional approaches alone, including the use of brachial BP, 
may not be sufficient to predict cardiovascular events. 
 
1.2 Aortic blood pressure. 
 
                  Aortic BP is often lower than brachial BP and because of the proximity of the aorta to 
end-organs, the hypothesis exists that aortic BP may be a more appropriate measure than 
brachial BP for predicting cardiovascular damage. Indeed, several lines of evidence suggest the 
superiority of aortic over brachial BP in predicting cardiovascular events or associating with end-
organ measures (Jankowski et al., 2008; Norton et al., 2012; Roman et al., 2007; Wang et al., 
2010). Indeed, in comparison with brachial BP, aortic BP may associate better with or 
independent of carotid intima-media thickness (Boutouyrie et al., 1999; Norton et al., 2012), left 
ventricular mass (LVM) (Boutouyrie et al., 1995; Chen et al., 1998; Deague et al., 2001; Lekakis 
et al., 2004; Norton et al., 2012; Roman et al., 2000), renal disease (Cohen and Townsend, 
2011; Safar et al., 2002; Safar et al., 2004), myocardial infarction (Hansen et al., 2006; Hirai et 
al., 1989), and coronary artery disease in aged individuals and in the general population 
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(Roman et al., 2007). However, in a meta-analyses of the data from several studies, aortic BP 
(central BP) produced only a trend effect (p=0.057) for predicting cardiovascular outcomes 
better than the brachial BP (Vlachopoulos et al., 2010) and aortic BP did not add to risk 
prediction beyond brachial BP in the Framingham Heart Study (Reddy, 2002). Nevertheless, a 
review by (Roman et al., 2007) and a meta-analysis (Ben-Shlomo et al., 2014) provide clear 
evidence for a stronger association between aortic as compared to brachial BP and end-organ 
measures. Hence, it is important to understand the potential differences in the effects of aortic 
as compared to brachial BP. There are several differences in the determinants of aortic as 
opposed to brachial BP, and these may in-part explain why aortic BP is more closely associated 
with cardiovascular end-organ changes than brachial BP. 
Arteries may be divided into two separate compartments based on their function. In this 
regard, “the conduit arterial system” consists mostly of branches distal to the aorta, and these 
arteries deliver blood to organs. On the other hand, the “pulsatile component” of the arterial tree, 
which consists mainly of the aorta and its immediate branches accommodate stroke volume 
ejected into vessels at a high pressure. Whilst the conduit system delivers blood at a high 
pressure, the pulsatile component serves a “cushioning effect” that is designed to reduce 
(dampen) pressure fluctuations arriving at the conduit system by way of the “windkessel” effect 
(Nichols et al., 2011; Safar, 1989; Safar et al., 2003). The “windkessel” effect is an effect named 
after early fire-engines which converted pulsatile flow (water was sucked into the conduit using 
a hand-held intermittent pump) into steady-state flow by dampening the flow pulsatility with the 
use of an air chamber (windkessel) and by creating resistance to flow in the fire hose. Hence, as 
with the “”windkessel system, the aorta is designed to dampen or reduce pressures, whilst more 
peripheral arteries are not.  
In essence the aorta serves less as a conduit vessel than other arteries and more as a 
capacitance (obviously not nearly to the same extent as the venous system) or rather 
“cushioning” vessel (it accommodates stroke volume while dampening pressure pulsatility). In 
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order for it to act as a “cushioning” vessel, it has a low degree of stiffness and a high degree of 
elasticity driven largely by a greater quantity of elastin in the wall of the aorta as compared to 
other vessels. In essence the aorta employs the capacity to stretch to dampen pulsatility just as 
the “windkessel” system used air to dampen pulsatility. In contrast, distal or more peripheral 
arteries such as brachial and femoral arteries, exhibit a higher stiffness, a lower degree of 
elasticity and less of an ability to stretch as compared to the aorta (Mitchell, 2009; Mitchell et al., 
2004; Nichols et al., 2011), a change which is accounted for by the gradual replacement of 
elastic tissue by smooth muscle as one moves from the aorta to the periphery. Peripheral 
arteries are stiffer not only because of a reduced elastin content, but also through a greater 
deposition of collagen as compared to the aorta (Nichols et al., 2011). As a consequence of a 
higher peripheral artery as compared to aortic stiffness (as well as to a small degree because of 
the narrower radius of peripheral arteries as compared to the aorta), peripheral arteries create a 
higher resistance to blood flow than the aorta or more central arteries. Peripheral arterial 
pressure is therefore higher than central arterial pressure (Nichols et al., 2011). However, this is 
generally the case for young adults, but with ageing, these differences in the physical 
characteristics of the aorta compared to more distal arteries changes. How does age alter the 
physical characteristics of the aorta compared to more distal arteries? 
As will be discussed in greater detail in subsequent sections, with the advancement in 
age (>50 years) (Mitchell et al., 2004; Oliver and Webb, 2003), there is fracture of elastin fibres 
in the aorta and a gradual replacement of elastic tissue with collagen. This then leads to 
stiffening of the aorta. However, because more distal arteries are not as affected by these 
changes as the aorta, with advanced aging aortic stiffness begins to approximate peripheral 
artery stiffness and this leads to pressures in the aorta increasing to similar values as those in 
peripheral arteries (Mceniery et al., 2005; Nichols et al., 2011; Townsend et al., 2015). How 
therefore does the magnitude and shape of the pulse wave in the aorta differ from the brachial 
artery and how is this affected by age?  
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Following left ventricular (LV) contraction, a pressure waveform (forward wave pressure 
or Pf) is generated by blood being ejected into the proximal aorta. The wave generated exhibits 
characteristics that can be analyzed in real time (Cohen and Townsend, 2011). As the wave 
travels along the arterial tree, its magnitude and shape changes (Avolio et al., 2009; García-
Espinosa et al., 2016; Nichols et al., 2011), i.e. the peak of the waveform increases in amplitude 
and becomes more visible and narrows (Figure 1.1), a change consequent to the previously 
mentioned differences in the physical characteristics of the vessels along the arterial tree 
(mainly due to an increased stiffness from the aorta to more peripheral arteries). Whilst diastolic 
BP remains unchanged from the aorta to peripheral arteries, the increased amplitude of the 
pulsatile pressure wave from the aorta to peripheral arteries results in increases in systolic BP. 
Hence, the difference between systolic and diastolic BP (pulse pressure [PP]) is amplified from 
the aorta to peripheral arteries. This is therefore called PP amplification. In this regard PP 
amplification is often striking in younger individuals who have a compliant aorta. However, as 
central aortic stiffness increases due to aging and several other factors as listed in Table 1.1, as 
previously indicated there is an increase in central aortic PP, while diastolic BP and mean 
arterial pressure (MAP) remain constant and brachial PP does not increase to the same degree 
(Cohen and Townsend, 2011; Mceniery et al., 2014). The consequence is that PP amplification 
decreases with ageing and the risk factors listed in Table 1.1. Hence, ageing and risk factor-
related increases in aortic stiffness reduce the difference between aortic and brachial PP. In 
other words, PP amplification is reduced as a consequence of increases in aortic stiffness 
mediated by ageing and a number of cardiovascular risk factors listed in Table 1.1. Moreover, 
brachial BP may not be a true predictor of end organ damage and this may be particularly 
evident in younger individuals (Cohen and Townsend, 2011). However, differences in stiffness  
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Figure 1.1. A diagrammatic representation of pressure amplification as it travels from the aorta 
to the peripheral arteries (Mceniery et al., 2014). 
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Table 1.1. Clinical and demographic conditions associated with increases in aortic stiffness  
 
Demographic features   CV risk factor   CV disease 
_________________________________________________________________________ 
Aging 
   
Hypertension 
 
Coronary heart 
Low birth weight 
 
Obesity 
  
Disease 
Menopausal status 
  
Smoking 
  
Congestive heart failure 
Lack of physical 
activity 
  
Hypercholesterolemia 
 
Fatal stroke 
Genetic 
  
Impaired glucose tolerance 
 
Primary non-CV diseases 
Background 
  
Metabolic syndrome ESRD 
Parental history of 
hypertension 
 
Type 1 diabetes 
 
Moderate chronic kidney disease 
Parental history of myocardial 
infraction Type 2 diabetes 
 
Rheumatoid arthritis 
Genetic polymorphisms 
 
Hyperhomocysteinaemia 
 
Systemic Vasculitis 
    
High CRP level Systemic lupus erythromatosus 
       _________________________________________________________________________ 
CV; Cardiovascular, ESRD; end stage renal disease, CRP; C-reactive protein. 
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between the aorta and the peripheral arteries is not the only factor that determines variations in 
PP amplification. What else contributes toward age-related changes in PP amplification? 
The pressure wave measured at any region of the arterial tree is not driven only by the 
forward (or incident) wave pressure (Pf), generated by LV ejection into the aorta, and hence by 
the extent of the stroke volume (determined by contractility and LV filling-Frank-Starling effect) 
and the magnitude of aortic impedance, (determined by aortic stiffness). Rather, the pressure 
wave measured at any region of the arterial tree is the sum of the forward wave as it meets a 
reflected or backward wave which generates a backward wave pressure (Pb). In this regard, 
forward waves are reflected at any point in the arterial tree where an impedance mismatch 
exists, such as arterial bifurcations. These reflected waves generate pressure waves that return 
to the LV (Avolio et al., 2009). In young healthy individuals, reflected waves return early in 
diastole, and enhance diastolic pressure, thereby increasing coronary blood flow. However, 
from young adulthood to old age, reflected waves return sufficiently early that they augment PP 
and systolic BP (SBP), thus placing an excessive load on the cardiovascular system (Avolio et 
al., 2009; Nichols et al., 2011) (Figure 1.2a). Wave reflections are dependent on distal arteries 
rather than the aorta, as distal arteries are more muscular than central arteries. The 
characteristics of these arteries such as their geometry and their vasoactive properties affect 
wave reflection (Safar et al., 2003). Vascular constriction, and a reduction in arterial cross-
sectional area at the site of arterial bifurcations, increases wave reflections and these changes 
cause the early return of the reflected wave, thereby augmenting PP and systolic BP (Nichols et 
al., 2011). Furthermore, vascular hypertrophy and remodelling (Mulvany and Aalkjaer, 1990), 
anatomical variations in the vascular network (Levy et al., 2001), chemical factors (sodium and 
nitric oxide level), genetic make-up of an individual, and ageing, tend to have effects on distal 
arterial function and hence modify either backward wave magnitude or timing, thus also 
producing changes in aortic PP and systolic BP (Safar et al., 2003). In essence, whilst Pf is  
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Figure 1.2a 
 
 
Figure 1.2b 
Figure 1.2. (a and b). Original recordings of an aortic pressure wave and the component 
forward and backward (reflected) wave pressures after wave separation analysis (a) and a 
comparison of the radial and aortic pressure waves (b). Pb; backward wave, Pf; Forward wave, 
RM; reflected wave magnitude, AIx; aortic augmentation index, PPc; central pulse pressure, Pa; 
augmented pressure, Rt; time to the foot of Pb, Ft; time to the peak of Pf. 
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determined largely by stroke volume and the impedance of the aorta (a higher stiffness 
generates a greater impedance and an increased Pf), Pb is determined by total peripheral 
resistance (TPR) and the vascular tone of medium-sized or smaller arteries (Avolio et al., 2009). 
The important question which arises from these facts is whether reflected waves are readily 
detected in brachial BP measurements? 
Backward wave pressure is lower than the Pf, and appears in the brachial artery as a 
second systolic shoulder with a lower peak than the wave generated by the forward wave 
pressure (Figure 1.2b). Hence, Pb is not as closely approximated by brachial artery BP 
measurements as is aortic BP. Nevertheless, in elderly populations there is an increase in the 
magnitude of Pb, and the peak of Pb as represented in the brachial pulse (second systolic 
shoulder) begins to approximate the peak of brachial BP (first systolic shoulder) (Nichols et al., 
2011). How are aortic backward wave effects determined in clinical or research practice? 
Aortic augmentation index (AIx), which is determined as the pressure difference between 
the second systolic peak and the first systolic peak of the aortic pressure wave, expressed as a 
proportion or percentage of aortic PP (Figure 1.2.a), is often used to evaluate the extent and 
magnitude of reflected wave pressures. Using this approach, some studies summarized in a 
meta-analysis have shown an association between aortic backward waves and cardiovascular 
events (Vlachopoulos et al., 2010). However, in other studies, these findings, independent of 
brachial BP, have not being supported (Mitchell et al., 2010). Importantly however, AIx is 
affected not only by the magnitude of Pb, but also by the magnitude of forward wave pressures, 
the duration of the forward wave (a longer duration increases the chances of the backward 
wave augmenting aortic PP), the time to wave reflection (a greater speed of wave reflection or a 
closer proximity to the LV of distal reflection sites, the greater the chance that the reflected wave 
returns early and augments aortic PP), heart rate (an increased heart rate increase AIx), body 
height (a shorter stature places reflection sites closer to the LV and hence produced earlier 
wave reflection) and other factors (Hope et al., 2005; Mitchell, 2006). Hence, it is possible that 
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AIx is an inappropriate surrogate of actual aortic backward wave pressure. More recently, focus 
has been on obtaining the reflected wave magnitude (RM) from wave separation analysis using 
the triangular flow wave (Kips et al., 2009; Westerhof et al., 2006), as depicted in Figure 1.2.a. 
Although there is an ongoing debate on this topic, several studies have demonstrated that 
although reflected wave pressures are smaller than the forward wave pressures, reflected wave 
pressures associate more strongly with end-organ changes and the development of CVD than 
forward waves (Booysen et al., 2015; Sibiya et al., 2015). 
In the present dissertation I evaluated whether relationships between aortic stiffness and 
an end organ measure (left ventricular mass) are explained by an impact of aortic stiffness on 
aortic forward wave or backward wave pressure and hence aortic PP. Hence, it is important that 
I elaborate more on the determinants of aortic stiffness; summarize the evidence to indicate that 
measures of aortic stiffness predict cardiovascular events; and review the possible explanations 
for the adverse effects of aortic stiffness on the cardiovascular system. 
 
1.3 Large artery (aortic) stiffness. 
 
An increase in large artery stiffness is a progressive, diffuse, and age-related process 
that takes place in all vascular beds (Izzo Jr, 2004), and the earliest detectable manifestation of 
structural and functional changes in the vascular wall (Cavalcante et al., 2011). The changes in 
large arteries that lead to increases in arterial stiffness are in essence arteriosclerotic changes. 
The mechanisms that govern the development of arterial stiffness are complex. However, as 
previously mentioned it is postulated that gradual fragmentation of elastin occurs from a young 
age through to adulthood (O’rourke and Hashimoto, 2007; Sun, 2015), and that this is as a 
result of constant exposure to the change in magnitude and frequency of the pulsatile pressures 
(Mceniery et al., 2010). In early childhood (<7 years), the medial layer of the arteries (including 
the aorta), develops elastic lamellae, and when this is completed, the gene responsible for this 
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is switched-off (Ott et al., 2011; Wagenseil and Mecham, 2009). However, due to body growth, 
obesity or weight gain, there is an increase in the aortic diameter, which results in thinning and 
remodelling of the elastic lamellae, the consequence of which is an increase in wall stress, 
tension and strain, thereby leading to the elastin lamellae being replaced with collagen tissue 
(Lam et al., 2010; Mitchell, 2015; Wagenseil, 2011). The arterial wall is progressively infiltrated 
with collagen which contributes to further stiffening and this collagen may become more cross-
linked such as occurs with the formation of advanced glycosylation end product formation in 
diabetes mellitus or an enhanced lysyl oxidase activity such as occurs in conditions such as 
hypertension (Kovacic et al., 2011). The increased collagen cross-linking results in a collagen 
molecule with an extremely high tensile strength which further stiffens the aorta. The 
fragmented elastin that occurs is believed to serve as a site for calcium deposition thereby 
leading to even further arterial wall stiffening (Dao et al., 2005; Mceniery et al., 2009). 
Importantly, clinically significant arteriosclerosis occurs in more than half of individuals aged 
over 60 years (Mceniery et al., 2005). 
Several factors may influence the degree of arterial stiffening including conventional 
cardiovascular risk factors (hypertension, diabetes mellitus, smoking, dyslipidemias, and 
obesity), the genetic make-up of an individual (Wilkinson et al., 2009; Zieman et al., 2005), and 
inflammation of the vascular wall, and many of these factors associated with urbanization 
(Wilkinson and Mceniery, 2012). These factors have been listed in Table 1.1. However, it is 
important to note that of all these factors, ageing and hypertension are the two most important 
accounting for most of the inter-individual variation in measures of arterial stiffness (Cecelja and 
Chowienczyk, 2009). Nevertheless, increases in aortic stiffness have been consistently 
demonstrated in diabetes mellitus and chronic kidney disease (Townsend et al., 2015). 
Increases in arterial stiffness may have several adverse effects on the cardiovascular system. 
These are in-part summarized in Figure 1.3. First, and as described in the aforementioned                                                                                                                                                          
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Figure 1.3. Mechanisms that may lead to the development of end organ damage with an elevated arterial stiffness. 
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section, increases in aortic stiffness enhance aortic impedance and subsequently increase 
aortic Pf and thus aortic PP and systolic BP (Nichols et al., 2011). The consequence is an 
increased load (cardiac or vascular) or wall stress which produces several effects including 
damage to the heart and vessels, atheroma formation in vessels and cardiovascular 
hypertrophy with several detrimental results. Just as an increased aortic stiffness may enhance 
Pf, there is also no reason to believe that a similar effect does not occur for the returning 
(backward) wave and that aortic stiffness does not increase backward wave pressures and 
hence aortic PP as well. Simultaneously, because of the lack of ability of a stiff aorta to 
accommodate blood during systole, there is less elastic recoil during diastole and thus 
peripheral blood flow is reduced in diastole and diastolic BP decreases. The consequence of a 
reduced diastolic BP may be an attenuated myocardial blood flow as coronary flow mainly 
occurs in diastole and this is to a large extent driven by the pressure gradient across the 
coronary bed. The increased aortic PP and systolic BP may not be adequately detected in the 
brachial artery because of the aforementioned differences that exist between the aorta and the 
brachial BP. The higher aortic pressure will then increase load on the cardiovascular system or 
produce an increased pulsatile flow in those organs where microvascular flow is indeed pulsatile 
(kidneys and the brain). Pulsatile flow may itself have deleterious effects on these tissue beds 
(Mitchell, 2008). Second, with arterial stiffening, the impedance mismatch between the aorta 
and more distal vessels may be diminished, the consequence being that the pulse wave 
generated is not appropriately `buffered` and this, in-turn, leads to excess transmission of 
pulsatile energy into the microvasculature with further damage to these organs (Hashimoto and 
Ito, 2011; Mitchell et al., 2011; O'rourke et al., 2010; Smulyan et al., 2016; Webb et al., 2012). 
This transmission of pulsatile energy driven by increases in pulsatile flow may not be associated 
with increases in PP. Third, an enhanced aortic stiffness also increases the speed of wave 
reflection resulting in an earlier return of the reflected wave, thus augmenting aortic PP with 
further increases in loads on the cardiovascular system (Nichols et al., 2011). Moreover, an 
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enhanced aortic stiffness may also result in an earlier return of the reflected wave independent 
of the speed of wave reflection. In this regard, it is proposed that the site of impedance 
mismatch is brought closer to the ascending aorta, thus shortening the distance that the 
backward wave has to travel. Although all three hypotheses are tenable, there is ongoing 
debate as to the validity or relative importance of one over the other hypothesis. In particular, 
the relative importance of an increased aortic stiffness on aortic PP as a cause of 
cardiovascular damage has been under scrutiny for some time. However, before addressing the 
issue of the evidence for and against this hypothesis, I will first discuss arterial stiffness as a 
cause or consequence of hypertension and then review the use of aortic pulse wave velocity as 
an index of aortic stiffness. 
It was initially thought that an increased arterial stiffness is a complication (end-organ 
effect) of hypertension. However, several studies have demonstrated that increases in arterial 
stiffness antedate and hence contribute toward the development of hypertension and this may 
be particularly true of isolated systolic hypertension (Alghatrif et al., 2013; Birru et al., 2011). 
Indeed, in a prospective study that followed participants for a mean duration of 7 years, an 
increased in aortic stiffness, together with increases in Pf (possibly also due to increases in 
aortic stiffness), and AIx (which may or may not have been mediated by an increased aortic 
stiffness) were all demonstrated to be associated with an increased risk for the development of 
hypertension (Kaess et al., 2012). In a mouse model of obesity, decreases in nitric oxide, 
increases in vascular wall matrix cross-linking and the production of inflammatory mediators 
were some of the proposed mechanisms that could lead to the development of increases in 
arterial stiffness and consequently hypertension. In this model arterial stiffness began to rise 
one month and systolic BP and PP began to increase 6 months after the diet was initiated, 
indicating arterial stiffness may precede hypertension. Moreover, weight loss was associated 
with reversal of the aforementioned changes (Weisbrod et al., 2013). 
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1.4 Pulse wave velocity. 
 
The velocity of pulse wave transmission along the aorta, which is estimated as carotid-
femoral pulse wave velocity (PWV), is a non-invasive and gold standard measure of arterial 
stiffness (Laurent et al., 2006;  Mancia et al., 2013;  Van Bortel et al., 2012). Mathematically it is 
expressed as PWV= L/Δt (m/s), where L is the distance in meters and Δt is the time interval in 
seconds and the relationship between PWV and arterial wall elasticity is expressed by the 
Moens-Koteweg equation: PWV=√E × h/2rρ, where E= Young`s modulus in the circumference 
direction, h= wall thickness of the vessel, r= inside radius of the tube, and ρ= density of the 
blood (approximately 1.05) (Mackenzie et al., 2002; O’rourke et al., 2002). Carotid-femoral PWV 
is the velocity of pulse wave travel along the aortic or aorto-iliac pathway and as inferred by the 
Moens-Koteweg equation, increases as aortic stiffness increases. In essence it is a measure of 
the velocity of the pulse waveform from the right common carotid artery to the right femoral 
artery (Van Bortel et al., 2012). This approach employs the foot-to-foot method of assessing the 
transit time of the pulse wave where the foot of the wave is defined as the point at the end of 
diastole, and the transit time is the time of travel of the foot of the wave over a known distance. 
This method is independent of the effect of wave reflection. This approach to assessing arterial 
stiffness has been extensively validated and inaccuracies of velocity assessment are minimal. In 
this regard, the shorter the distance externally between the two recording sites, the greater the 
error in transit time (Laurent et al., 2006), and hence velocity is best measured across the whole 
aortic bed. To determine the distance travelled either the use of the direct distance between the 
carotid and femoral sites is measured, or the distance from the carotid site to the sternal notch 
is subtracted from the distance from sternal notch to the femoral site. Presently there is 
agreement that the best approach to assessing the distance travelled by the pulse waveform is 
to take 80% of the direct distance between the carotid and femoral sites (Van Bortel et al., 
2012). 
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Although there are several alternative methods for the assessment of arterial stiffness 
apart from PWV (including carotid ultrasonography) (Mackenzie et al., 2002), cardiovascular 
magnetic resonance imaging (Ibrahim et al., 2010), cardio-ankle vascular index  (Wang et al., 
2009) and echocardiography (Laurent et al., 2006; Vlachopoulos et al., 2015), none of these 
techniques are as easy to perform or as reproducible as carotid-femoral PWV and none of these 
assessments have as extensive evidence as aortic PWV for predicting risk beyond conventional 
risk factors. Moreover, the technology to measure aortic PWV is by no means as expensive as 
the technology required to perform magnetic resonance imaging or ultrasound approaches. With 
respect to the measurement of aortic PWV, there are several semi-automated devices available 
for the measurement including the Complior, SphygmoCor, Pulse pen, Periscope, and Vasera 
devices (Nichols et al., 2011). The SphygmoCor and Pulse Pen devices calculate the time delay 
between two consecutive points in cardiac cycle using the R-wave of the Electrocardiogram 
(ECG) as a guide. 
 
1.4.1 Age-related changes in aortic PWV 
 
Several studies have described the age-related changes in aortic PWV and these 
findings have largely been consistent. However, there is some discrepancy as to how age-
related increases in aortic PWV relate to aortic pressures. What are the consistencies and what 
are the discrepancies between studies? Although there is agreement that age is the strongest 
determinant of aortic PWV with PWV increasing by approximately 1 m/sec every 10 years, there 
is disagreement on the rate of change that occurs. Some studies have shown that the effect of 
age on PWV is a linear relationship (Mitchell et al., 2004; Smulyan et al., 2001). However, other 
studies evaluating the effect of age on PWV and aortic PP show a non-linear (closer to an 
exponential) relationship (Mitchell, 2015). In this regard, several studies show that aortic PWV 
increases only modestly between the ages of 45-65 years, while aortic PP begins to increase 
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significantly between the ages of 20-39 years (Hodson et al., 2015;  Mitchell et al., 2010), and 
that this is driven to a large extent by aortic backward wave magnitude (Booysen et al., 2015).  
However, after the age of 65 years, both PWV and aortic PP increase exponentially (Hodson et 
al., 2015; Mitchell et al., 2010). Although, as previously indicated aortic stiffness may influence 
aortic PP through an impact on aortic backward wave pressures and AIx (through an earlier 
return of the reflected wave), the limited effect of aortic PWV (the gold-standard measure of 
aortic stiffness) on AIx is nevertheless highlighted by the fact that AIx increases substantially 
between the ages of 45-65 years, which is several decades prior to when PWV begins to 
increase substantially and then AIx falls again after 65 years of age, when PWV is increasing 
rapidly.  
 
1.4.2 Pulse wave velocity and cardiovascular risk 
 
Carotid-femoral PWV is now a well-established predictor of cardiovascular events 
beyond conventional risk factors, including MAP (distending pressure which increases arterial 
stiffness through passive effects), and brachial systolic BP and PP (Baumann et al., 2014; Ben-
Shlomo et al., 2014; Mitchell et al., 2010; Russo et al., 2012; Vlachopoulos et al., 2010; Weber 
et al., 2012; Woodard et al., 2014), and these findings have been summarized in a meta-
analysis of several studies (Vlachopoulos et al., 2010), and an individual participant meta-
analysis (Ben-Shlomo et al., 2014). Carotid-femoral PWV predicts the majority of cardiovascular 
events including stroke and myocardial infarction (Ben-Shlomo et al., 2014), and the ability of 
carotid-femoral PWV to predict events is noted across several co-morbidities (elderly and 
young-to-middle aged, the general population and clincial populations, smokers and non-
smokers, diabetics and non-diabetics, hypertensives and normotensives and those with or 
without chronic kidney disease) (Ben-Shlomo et al., 2014). For a 1 standard deviation increase 
in aortic PWV the risk (hazards ratio) is estimated to be 23% greater than normal for a coronary 
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event, 28% above normal for a stroke, and 30% above normal for a cardiovascular event (Ben-
Shlomo et al., 2014). Aortic PWV adds to the ability to detect risk beyond the Framingham Risk 
Score and other risk scoring systems (Laurent and Boutouyrie, 2013) and adds as much as 
other measures of end-organ damage including left ventricular hypertrophy, carotiod plaque and 
estimated glomerular filtration rate to risk prediction (Sehestedt et al., 2010). Importantly, 21.8% 
of those at moderate risk are reclassified into a higher risk on the basis of aortic PWV and 
14.3% at intermediate risk are reclassified into a higher risk, whilst only 1.4% are reclassified 
into a lower risk (Mitchell et al., 2010; Sehestedt et al., 2012). In a 51 month follow-up of 
patients with end-stage renal disease a change in aortic PWV predicted cardiovascular mortality 
independent of confounders including brachial BP (Guerin et al., 2001). Hence, there is some 
evidence that interventions leading to an improved aortic PWV predict events. Because of the 
significant evidence in favour of aortic PWV predicting cardiovascular events beyond 
conventional risk factors, guidelines for the diagnosis and management of hypertension now 
recommend the measurement to predict risk (Mancia et al., 2013). However, these guidelines 
list aortic PWV as an end-organ change (a composite measure of the complications of ageing, 
hypertension and several other risk factors) rather than a reflection of a haemodynanmic 
change (an increased aortic stiffness) with several possible adverse effects on the heart and 
vessels (as discussed in the section on aortic stiffness).  
 
1.4.3 Could the brachial BP-independent ability of aortic stiffness to predict risk be 
mediated by an effect on aortic BP?  
 
There are several reasons why aortic PWV, the gold-standard measurement of aortic 
stiffness, predicts risk independent of brachial BP and these have largely been described in 
previous discussion. To summarize, aortic BP may produce an increase in aortic Pf and hence 
PP, systolic BP and wall stress in the heart or vessels. However, because of PP amplification, 
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these effects are not readily detected at the brachial artery. Second, aortic stiffness may 
increase flow pulsatility (without necessarily increasing PP) by reducing the impedance 
mismatch that exists between the aorta and more distal vessels. Third, an increased aortic 
stiffness may produce earlier reflected waves and reflected waves of greater magnitude, and 
hence enhance aortic AIx and aortic PP. Fourth, increases in aortic PWV may reflect an end-
organ change. What is the evidence for or against aortic PWV mediating effects on end-organs 
through increases in aortic PP? 
Importantly, the Framingham Heart Study demonstrated that aortic PWV, but not aortic 
PP, PP amplification or AIx predicts risk beyond brachial PP (Mitchell et al., 2010). Hence, there 
is question as to whether aortic PWV mediates cardiovascular damage through effects on Pf or 
Pb and AIx and hence aortic PP. Is there evidence for relations between aortic PWV and end-
organ changes independent of brachial BP that may be mediated by increases in aortic Pf, Pb, 
AIx and PP? In this regard, one should not expect aortic PWV to modify renal or brain function 
through increases in PP (although this could happen). The adverse effects of aortic PWV on 
these organs is possibly through an increased flow pulsatility (unlike other organs flow in the 
kidneys and brain is pulsatile) independent of aortic PP. However, the target organ that is most 
likely affected by aortic stiffness-induced increases in aortic Pf and PP independent of brachial 
BP is left ventricle (LV) (see Figure 1.3). Indeed, as indicated in the above discussion PWV 
predicts not only stroke (or renal damage), but also coronary heart disease (Ben-Shlomo et al., 
2014;  Vlachopoulos et al., 2010). Hence the question arises as to whether aortic PWV is 
associated with LV mass (LVM) independent of brachial BP? In this regard, LV hypertrophy 
(LVH) is a well-recognized predictor of cardiovascular risk independent of conventional BP 
measurements (Casale et al., 1986; Drazner et al., 2004; Gardin et al., 2001; Ghali et al., 1998;  
Levy et al., 1990; Levy et al., 1994; Verdecchia et al., 2001). Even in the absence of arterial 
hypertension, LVM is an independent risk factor for cardiovascular events (Gardin et al., 2001). 
Importantly, irrespective of baseline conventional BP and treatment for hypertension, the 
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presence of LVH doubles the risk for cardiovascular events including myocardial infarction, and 
unstable angina (Verdecchia et al., 2001). Left ventricular hypertrophy is also associated with 
the severity of coronary disease independent of conventional BP (Ghali et al., 1998). In addition, 
independent of conventional BP, LVH is associated with a greater relative risk of coronary 
multivessel disease (Liao et al., 1995). 
Many studies have shown that indices of arterial stiffness are associated with LVM 
(Baguet et al., 2000; Bell et al., 2015; Bouthier et al., 1985; Boutouyrie et al., 1995; Chen et al., 
1998; Chobanian et al., 2003; Deague et al., 2001; Gates et al., 2003; Iketani et al., 2000;  
Kobayashi et al., 1996; Leoncini et al., 2006; Libhaber et al., 2008; Ohyama et al., 2016;  
Roman et al., 2000; Roman et al., 1996; Tatchum-Talom et al., 1995). In this regard however, a 
number of studies have indicated that the relationship between indices of arterial stiffness and 
LVM is not independent on conventional BP measured at the brachial artery (Baguet et al., 
2000; Bell et al., 2015; Bouthier et al., 1985; Chen et al., 1998; Deague et al., 2001; Roman et 
al., 2000; Roman et al., 1996). In contrast, three human studies suggest that arterial stiffness 
effects on LVM are independent of brachial artery BP (Lekakis et al., 2004; Leoncini et al., 2006;  
Libhaber et al., 2008). One study was conducted in a very small study sample (Lekakis et al., 
2004). The second study related the less well recognized ambulatory arterial stiffness index with 
LVM (Leoncini et al., 2006). Nevertheless the third study, performed by our group, showed 
strong independent relations between aortic PWV and LVM in women (Libhaber et al., 2008). 
However, no study has assessed whether these brachial BP-independent relations between 
aortic PWV and LVM reflect an impact of aortic PWV on Pf, Pb, and hence a greater central 
aortic PP. 
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1.5 Problem statement 
 
As indicated in the aforementioned discussion, aortic stiffness, as indexed using aortic 
PWV, is an established predictor of cardiovascular events beyond conventional risk factors, 
including brachial BP (Ben-Shlomo et al., 2014; Vlachopoulos et al., 2010), the measurement of 
aortic PWV is recommended by hypertension guidelines for risk prediction (Mancia et al., 2013)  
In this regard, individual participant meta-analysis (Ben-Shlomo et al., 2014), shows an ability 
of PWV to predict outcomes across a wide adult age range and in a variety of co-morbidities 
(Ben-Shlomo et al., 2014). The reason why PWV predicts outcomes beyond conventional risk 
factors is nevertheless unclear with guidelines listing it as an end-organ change (Mancia et al., 
2013). However, there are several possible mechanisms that may explain the impact of PWV 
on risk prediction beyond brachial BP. 
An increased aortic stiffness may reduce the impedance mismatch between the aorta 
and more distal vessels, resulting in a greater pulsatile flow and microvascular damage to the 
kidneys and brain (Chirinos et al., 2012; Wang et al., 2010; Weber et al., 2012). However, PWV 
predicts not only stroke (or renal damage), but also coronary heart disease (Ben-Shlomo et al., 
2014; Vlachopoulos et al., 2010), and hence alternative explanations for the ability of PWV to 
risk predict are required. In this regard, increases in aortic PWV reflect an enhanced aortic 
stiffness which amplifies central aortic PP (PPc). This occurs by creating an impedance to 
ventricular ejection and consequently producing increases in aortic forward (Pf) and possibly 
backward wave (Pb) pressures (Zamani et al., 2014). An enhanced aortic PWV also increases 
the speed of wave reflection resulting in an earlier return of the reflected wave, thus 
augmenting PPc (Zamani et al., 2014).  Therefore, an increased PWV results in a greater Pf or 
Pb and PPc which amplifies LV and large vessel load which may, in turn, cause damage to 
these structures. In this regard, evidence to support this notion are reports that PWV is 
associated with LV mass (LVM) (Booysen et al., 2015; Hashimoto and Ito, 2011; Sibiya et al., 
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2015; Zamani et al., 2015). However, no study has assessed whether these relations reflect an 
impact of aortic PWV on Pf, Pb and hence a greater PPc. 
 
1.6 Aims 
 
In the present study I therefore aimed to evaluate the contribution of Pf, Pb, and PPc to 
brachial BP-independent relations between PWV and LVMI in a relatively large randomly 
selected community sample of African ancestry.                                                    
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Chapter 2 
Materials and Methods 
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2.1 Study population. 
 
The present study was conducted according to the guidelines outlined in the Helsinki 
Declaration. The study was approved by the University of the Witwatersrand Committee for 
Research on Human Subjects (approval number: M02-04-72 and renewed as M07-04-69 and 
M12-04-108). Participants gave informed, written consent. The study design has been 
described previously (Norton et al., 2012; Norton et al., 2008; Redelinghuys et al., 2010; 
Woodiwiss et al., 2009). The study is cross-sectional. Nuclear families (either both parents and 
at least one sibling or one parent and at least two siblings) of black African descent, with 
siblings older than 16 years of age were randomly recruited from the South Western Townships 
(SOWETO) of Johannesburg, South Africa (from the population census figures of 2001). 
Participants were of the Nguni (Zulu, Xhosa, Ndebele, and Swati), Sotho (South, North Sotho 
and Tswana) or Venda chiefdoms. The sample largely consisted of Nguni and Sotho chiefdoms. 
The lack of representation from the Venda chiefdom reflects a lack of individuals of this 
chiefdom residing in these areas of Johannesburg. No subjects of mixed, Asian, or European 
ancestry were recruited and no Khoi-San subjects were recruited. A lower age limit of 16 years 
was included to avoid the impact of rapid growth on LV mass and BP. Random recruitment of 
community participants was based on the following approach: Street names and addresses of 
households were obtained from the department of home affairs, 2001 census. These 
households were allocated numbers, and numbers were selected from a random number 
generator. People residing in informal dwellings or institutions/ homes were not recruited. A 
photograph of an example of formal dwellings in SOWETO is given in Figure 2.1. Of the 1197 
participants randomly recruited, in a sub-study, 749 had left ventricular mass index (LVMI) 
determined by echocardiography, and all aortic haemodynamic assessments. 
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Figure 2.1. Examples of formal dwellings in the suburban region where people were recruited 
for this study. 
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2.2 Site where measurements were conducted. 
 
The measurements were carried out at the Cardiovascular Pathophysiology and 
Genomics Research Unit (CPGRU) facility, School of Physiology, Faculty of Health Sciences, 
University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, South Africa. 
Participants were transported to the CPGRU on Wednesdays and Thursdays, which are the 
clinic days between 9.00 hours to 13.00 hours, during which time all the required measurements 
were carried out. 
 
2.3 Clinical, demographic and anthropometric measurements. 
 
A standardized questionnaire was administered, to obtain demographic and clinical data. 
The questionnaire was made available in English, but trained study assistants (a nursing sister 
and trained technician) familiar with the home (first) languages assisted with the completion of 
each questionnaire. Only same-sex assistants were used to assist each family member with the 
completion of the questionnaire. Assistance was only provided when requested. Nonetheless, 
the majority of participants were reasonably proficient in the English language (primary and 
secondary education is largely conducted in the English language). Study assistants first visited 
homes of subjects that agreed to participate in the study in order to develop a trusting 
relationship. The questionnaire was only completed at a subsequent clinic visit and then 
ambiguities checked by performing a follow-up home visit. If family members were absent at 
follow-up home visits, data was checked with them personally via telephonic conversations 
whenever possible. Ambiguities in answers to the questionnaire were detected by an 
independent observer prior to the second home visit. A pilot study was conducted in 20 subjects 
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to ensure that data obtained in the questionnaires were reproducible when obtained with the 
assistance of two separate study assistants. 
The questionnaire sought specific answers to date of birth, gender (designated as either 
male of female), past medical history, including the presence or absence of hypertension, 
diabetes mellitus, renal disease, prior cardiovascular events, such as myocardial infarction, 
stroke, and angina pectoris. Past or current use of medications (analgesics), antihypertensive 
use (pills use to lower blood pressure) and pills used to lower blood sugar were also evaluated. 
Cigarette smoking history was assessed as either smoked in the past, or smoking presently. 
Previous and present history of the consumption of alcoholic beverages (beer, traditional beer, 
or any form of alcohol and daily quantity) was assessed. Caffeine consumption (number of cups 
of coffee), frequency of physical activity and family history of hypertension, diabetes mellitus, or 
heart disease was also assessed. For female participants, the history of monthly menstrual flow, 
previous or present use of contraceptive pills, and previous history of past pregnancy, were also 
evaluated. Most of these questions required a simple response of either “YES” or “NO” as 
answers. If there was any uncertainty as to the answers given to the questions asked at the 
initial visit, then this information, was requested during the next visit. 
 
2.4 Blood pressure measurements. 
 
Blood pressure (BP), was measured by a trained nurse-technician, according to 
guidelines of the American Heart Association and European Society of Hypertension 
recommendation using a standard mercury sphygmomanometer (O'brien et al., 2003;  Pickering 
et al., 2005). The nurse was of the same ethnic origins (black African) as the participants and 
had previously lived in SOWETO. After being trained in the procedure, including being shown 
pitfalls of BP measurement (positioning of the cuff, positioning of the arm, first estimating 
systolic BP using a radial pulse measure in order to avoid increasing cuff pressures too high, 
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detecting auscultatory gaps, releasing valve pressure at the correct speed, using the correct cuff 
size, etc.), the assistant had to demonstrate an ability to perform the procedure on 20 subjects. 
The study assistant was then tested on her ability to measure BP in two ways. First she was 
asked to measure BP on a separate group of 20 subjects including patients with hypertension 
and their readings had to be within 4 mm Hg of a doctors/nursing sister’s readings obtained with 
a stethoscope with two ear pieces. Second, the study assistant was asked to watch a video 
showing a simulated mercury column with Korotkoff sounds where observers were tested on 
their ability to detect phase I and V sounds under different circumstances including in the 
presence of a wide auscultatory gap and where phase V Korotkoff was taken as a “muffling” 
rather than a “disappearance” of sounds (Blood Pressure Measurement, British Medical Journal, 
BMA House London). To qualify as an observers all of her readings (n = 20) had to be within 4 
mm Hg of the reference standard.  
Blood pressure was recorded to the nearest 2 mm Hg. Korotkoff phases I and V were 
employed to identify systolic and diastolic BP respectively, and care was taken to avoid 
auscultatory gaps. Five consecutive BP readings were obtained, at least 30 seconds apart in a 
sitting position after 10 minutes of rest using an appropriately sized cuff for each of the 
participants, and the average of the five readings was subsequently employed for statistical 
analysis. Standard cuffs were used with an inflatable bladder with a length of 22 cm and a width 
of 12 cm, except when arm circumference exceeded 31 cm larger cuffs with a 31 x 15 cm 
bladder were employed. Participants were considered to be hypertensive if they had a systolic 
BP of ≥ 140 mmHg and/or a diastolic BP of ≥ 90 mmHg, or were receiving antihypertensive 
medication.   
 
2.5 Anthropometry. 
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Body height, body weight, and waist circumference (WC) were measured. Body weight 
was measured using an adult weighing scale, and approximated to the nearest 0.5 kilograms. 
Height was measured using a Stadiometre and expressed in metres. Body mass index (BMI) 
was then derived from weight and height as weight in kg, divided by height squared (kg/m2), and 
this was employed as a marker of adiposity. Waist circumference was assessed using a 
standard tape measure at a point midway between the last rib and the iliac crest during normal 
breathing with the arms outstretched and this was used a measure of abdominal obesity. Waist 
circumference was measured to the nearest 0.1 centimetres. Obesity was defined as a BMI of 
≥30 kg/m2 and overweight as a BMI ≥25 kg/m2. In addition abdominal obesity was defined as a 
WC ≥88 cm in women and ≥102 cm in men (Williams, 2002). 
 
2.6 Blood analysis. 
 
After an overnight fasting period of 12 hours in all participants, a trained nurse-technician 
obtained venous blood samples from the participants. Appropriate blood samples were then 
centrifuged and serum or plasma separated from the samples. Standard laboratory blood tests 
for renal function (creatinine, sodium and potassium concentrations), liver function (alanine and 
aspartate transaminases, alkaline phosphatase, total bilirubin, and conjugated and 
unconjugated bilirubin concentrations), haematological parameters (full blood count), lipid 
profiles (total, LDL and HDL cholesterol concentrations) and percentage glycated haemoglobin 
were analysed. These data were used to identify medical conditions and syndromes. A “spot” 
urine analysis was also performed to screen for major clinical conditions, such as diabetes 
mellitus and renal pathology. The National Health Service Laboratory (NHSL) was utilised (on 
contract) for blood measurements to ensure reproducibility and reliability as these laboratories 
have been accredited as fulfilling all criteria of “good laboratory practice”. Serum cholesterol 
concentrations were analyzed with a cholesterol reagent on the Advia chemistry instrument 
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(Siemens, South Africa) (Urbina et al., 2002). Serum HDL cholesterol concentration was 
analyzed by applying both heparin-calcium precipitation and agarose gel electrophoresis 
(Urbina et al., 2009). Diabetes mellitus or an abnormal blood glucose control was defined as 
use of insulin or oral anti-hyperglycaemic medications, or a glycated haemoglobin value > 6.1% 
(Bennett et al., 2007). Menopausal status was confirmed with measures of plasma follicle 
stimulating hormone concentrations. Dyslipidaemia was defined as serum levels of total 
cholesterol >6.5 mmol/l, LDL cholesterol >4.0 mmol/l, HDL cholesterol <1.2 mmol/l in females, 
and HDL cholesterol <1.0 mmol/l in males. An elevated serum creatinine concentration was 
defined as ≥107 µmol/l in females, and ≥115 µmol/l in males (Williams, 2002).  
 
2.7 Echocardiography. 
 
Echocardiographic measurements were performed by two experience observers 
(Professor Carlos Libhaber a trained cardiologist and Professor Angela Woodiwiss and 
experienced echocardiographer) who were unaware of the clinical data of the participants. All 
measurements were recoded and stored offline. I performed echocardiography on a number of 
patients (n=160) under the guidance of Professor Woodiwiss to ensure that I was able to obtain 
comparable images and that I understood the pitfalls of the measurement. However, the data 
employed for analysis was that obtained by Professors Libhaber and Woodiwiss as they have 
demonstrated a low degree of inter and intra-observer variability (Norton et al., 2008;  
Woodiwiss et al., 2009). Echocardiography was performed with the participants placed in the 
partial left decubitus position, with the head of the bed elevated to the 30 degrees position. A 
standard 12-lead electrocardiogram was used to identify diastolic and systolic periods of the 
cardiac cycle. Participants were first assessed for mitral and aortic valve abnormalities using 
two-dimensional (2D) guided colour Doppler imaging. To determine LVM, the transducer probe 
(2.5 MHz) was placed over the left intercostal space at the mid-clavicular line, with the probe 
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marker pointing to the right shoulder in order to obtain a long axis parasternal view window. Left 
ventricular (LV) dimensions were obtained from 2D guided (long axis parasternal view) M-mode 
echocardiography in the short axis of the LV, according to guidelines (Sahn et al., 1978). To 
obtain M-Mode images in the short axis of the LV, a sample bar was placed at right angles to 
the LV posterior wall, and as close to the mitral valve as possible without the images of the 
mitral valve appearing in the M-Mode recording. The interventricular septal wall thickness (IVS) 
at end diastole and end systole, the posterior wall thickness (PWT) at end diastole and end 
systole and the end diastolic and end systolic internal dimensions of the LV were measured only 
when appropriate visualization of both the right and the left septal surfaces occurred and where 
the endocardial surfaces of both the septal and posterior wall were clearly visible (as depicted in 
Figure 2.2). Left ventricular mass was calculated using an anatomically validated standard 
formula (Devereux et al., 1986), and indexed to height1.7 (LVMI). Left ventricular hypertrophy 
(LVH) was defined as an LVMI-height1.7 >80 g/m1.7 for men, and 60 g/m1.7 for females (Chirinos 
et al., 2010).  
 
2.8 Aortic haemodynamics. 
 
After participants had rested for 15 minutes in the supine position, the waveform at the 
radial (dominant arm) pulse was recorded by applanation tonometry during an 8-seconds period 
using high-fidelity SPC-301 micromanometer (Miller Instrument, Inc., Houston, Texas) 
interfaced with a computer employing SphygmoCor, Version 9.0 software (AtCor Medical Pty. 
Ltd., West Ryde, New South Wales, Australia) (see Figures 2.3). The pulse wave was 
calibrated by manual measurement (auscultation) of the brachial BP, taken immediately before 
the recordings. The peripheral pressure waveform was converted into a central aortic waveform 
using a validated generalized transfer function incorporated in SphymoCor software (see 
Figures 2.4). Recordings where the systolic or diastolic variability of consecutive waveforms  
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Figure 2.2 Two Dimensional M-mode guided echocardiographic image to assess LV 
dimensions. A is interventricular septal wall thickness in diastole, B is left ventricular end 
diastolic diameter, C is posterior wall thickness in diastole, D is interventricular septal wall in 
systole, E is left ventricular internal diameter in systole, and F is posterior wall thickness in 
systole 
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Figure 2.3 SphygmoCor device employed to determine aortic haemodynanmics. A is the 
SphygmoCor machine, B are electrocardiogram leads, and C is the pulse pen. 
 
 
 
 
 
A 
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                                                                                        Time (ms) 
Figure 2.4 Examples of a pulse wave recording obtained to determine central haemodynamics. 
The figure shows the radial artery pulse wave obtained from applanation tonometry (lower left 
panel) and the aortic pulse wave derived from a population-based transfer function built into the 
software (lower right panel). See text for a further description. Quality control assessments are 
shown in the top panel. Sp, systolic blood pressure (BP); Dp, diastolic BP; MP, mean arterial 
pressure; PP, pulse pressure. 
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exceeded 5% or the amplitude of the pulse wave signal or were less than 80Mv were discarded. 
All measurements were made by a single experienced technician, unaware of the clinical history 
of the participants and with a low degree of intra-observer variability and a high degree of 
reproducibility. 
Central aortic PP was determined as the difference between aortic systolic and the 
diastolic BP. Aortic backward wave pressure (Pb) and forward wave pressures (Pf) were 
determined using SphygmoCor software which separates the aortic waveform using a triangular 
flow wave (Tade et al., 2017). In the present study I did not employ a “physiological aortic flow 
waveform” approach to wave separation analysis as in a pilot study conducted in 26 
participants, the previously described physiological aortic flow waveform (Tade et al., 2017), did 
not closely approximate aortic flow waveforms in the present community sample. Moreover, a 
wide variety of aortic flow waveforms were identified in the 26 participants studied, precluding 
the possibility of identifying a single “representative waveform” which could be used for wave 
separation analysis. Although the “triangular flow waveform” approach generates a hypothetical 
waveform, in 392 participants our group have previously validated this approach by separating 
the forward and backward waves using aortic flow waveforms derived from aortic velocity and 
diameter measurements obtained using echocardiography (five-chamber view) (Tade et al., 
2017). In this regard, our group have shown similar relations between Pf or Pb and LVMI when 
Pb or Pf were derived from wave separation analysis employing actual flow measurements 
versus Pb or Pf derived from the triangular waveform approach to wave separation analysis 
(Tade et al., 2017). 
Aortic PWV was measured from the sequential waveform measurements as described 
previously (Shiburi et al., 2006). Pulse wave transit time i.e. the duration taken for the wave to 
travel from the carotid to the femoral site, was determined as the difference between the time 
taken to generate the femoral and the carotid pulse wave forms, as shown in Figure 2.5. To 
assess differences in time of the generation of the carotid and femoral pulse wave form, a 3- 
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Time of aortic wave travel=A-B        
 
Figure 2.5 Assessment of aortic pulse wave velocity (PWV). Femoral and carotid artery pulse 
waves are obtained using applanation tonometry. Together with simultaneous 
electrocardiographic recordings aortic pulse wave velocity (PWV) is calculated. The red lines 
indicate the time between electrical events and the arterial pressure changes in the carotid and 
femoral arteries used to calculate PWV. See text for a further description. 
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lead ECG was performed simultaneously with pulse wave form sampling. The time delay in the 
pulse waves between the carotid and femoral locations was determined using the R wave of the 
ECG as a fiducial point. Pulse transit time was taken as the average of 10 consecutive beats. 
The distance which pulse wave travels was determined as difference between distance from the 
femoral sampling site to the suprasternal notch (site B), and the distance from the carotid to the 
suprasternal notch is termed (site A). Pulse wave velocity was the calculated as a distance in 
meters divided by the transit time in seconds. Values of PWV >10 m/sec were considered as an 
elevated aortic PWV (Van Bortel et al., 2012). 
 
2.9 Data analysis 
 
For database management and statistical analysis, SAS software, version 9.3 (SAS 
Institute Inc., Cary, NC) was employed. Multiple linear regression analysis was performed to 
determine the independent relations between aortic haemodynamic parameters and LVMI 
(continuous data). Multivariate adjusted logistic regression analysis was performed to determine 
the independent relations between aortic haemodynamic parameters and LVH (discrete data). 
Adjustments included in multivariate models were those correlated with central haemodynamic 
variables and LVMI in bivariate analysis. To determine probability values, further adjustments 
for non-independence of family members was performed using non-linear regression analysis 
(mixed procedure as defined in the SAS package). Regression coefficients were compared with 
Z statistics.  
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3.1 Characteristics of the participants. 
 
Table 3.1 shows the clinical and demographic characteristics of all participants. In the 
sub-group that had echocardiography, 63.8% were females, while 36.2% were males. Aortic 
PWV and the proportion of participants receiving anti-hypertensive therapy were modestly 
greater in those in whom echocardiography was not available. Otherwise, no marked 
differences in the clinical and demographic characteristics of the participants included in the 
sub-study were noted as compared to those not included in the sub-study. The study sample 
was largely young-to-middle aged. 1.7% of the participants had a history of CVD. Importantly, a 
high proportion of participants had hypertension, and a significant proportion were not receiving 
anti-hypertension therapy. Moreover, 33.9% of all participants and 56.7% of participants 
receiving anti-hypertensives therapy had uncontrolled hypertension. 44.5% of participants had 
LVH. 
 
3.2 Relationship between PWV and aortic haemodynamics. 
 
Aortic PWV was directly correlated with aortic PPc, Pf, and Pb in both women and in 
men (Figure 3.1). 
 
3.3 Relations between PWV or alternative aortic hemodynamic parameters and LVMI. 
 
In multivariate adjusted models with either brachial SBP or PP (Figure 3.2) or mean 
arterial pressure (MAP) (Table 3.2) in the models, PPc and Pb, but not Pf were independently 
associated with LVMI in both women and men. However, independent of brachial BP, PWV 
was associated with LVMI in women, but not in men (Figure 3.2 and Table 3.2). Moreover, Rt  
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Table 3.1 Characteristics of the study sample. 
 
                     Echocardiographic  No  
                           Sub-study echocardiography 
____________________________________________________________________ 
Sample size (% Female)            749 (63.8)   448 (67.4)              
Age (years)                          44.7±18.4   44.9±19.1   
Body mass index (kg/m2)              28.9±7.3     29.7±8.4   
% Obese                             41.7         43.6      
Regular tobacco (% subjects)                         16.2        15.7 
Regular alcohol (% subjects)                        19.9         22.3 
% with DM or HbA1c>6.1%                                          23.8         24.7 
% Hypertensive                   45.1         42.8 
% treated for hypertension                   25.9         19.8* 
Pulse rate (beats/min)                                                 66±11                  66±12   
Brachial SBP/DBP (mm Hg)                                 129±22/83±12     130±23/84±12                            
Brachial pulse pressure (PP)(mm Hg)                        45±15                   45±15                  
Central aortic SBP (mm Hg)                                      119±22                 121±22      
Central aortic PP (PPc) (mm Hg)                                 35±15                 36±15                      
Aortic forward wave pressure (Pf) (mm Hg)                  24±9                  24±8      
Aortic backward wave pressure (Pb) (mm Hg)              17±8                  18±8      
Aortic pulse wave velocity (PWV) (m/sec)                 6.10±2.69            6.57±2.47**      
Left ventricular mass index (g/m1.7)                             66.4±23.9                 - 
_____________________________________________________________ 
Data expressed as mean ± SD or proportions. DM, diabetes mellitus; HbA1c, glycosylated 
haemoglobin; BP, blood pressure; SBP, systolic BP; DBP, diastolic BP. *p<0.05, **p<0.005 vs 
echocardiographic sub-study group. 
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Figure 3.1 Bivariate relations between aortic (carotid-femoral) pulse wave velocity (PWV) and 
alternative haemodynamic factors in women and men of a community sample of African 
ancestry. See table 3.1 for additional abbreviations. 
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Figure 3.2. Brachial systolic blood pressure (SBP) or pulse pressure (PP) adjusted relations 
between aortic haemodynamic parameters and left ventricular mass indexed to height1.7 (LVMI) 
in women and men of a community sample of African ancestry. See table 3.1 for additional 
abbreviations. *Adjustments are for haemodynamic parameter as stated as well as age, body 
weight, pulse rate, regular smoking, regular alcohol intake, diabetes mellitus or an HbA1c>6.1% 
and treatment for hypertension. 
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Table 3.2 Relationship between aortic haemodynamics parameters and left ventricular mass 
index before and after adjustments for mean arterial pressure (MAP). 
 
                       Women (n=478)                           Men (n=271) 
                   Adjustors             Partial r                 p-value          Partial r              p-value   
                 (95% CI)              (95% CI)     
________________________________________________________________________ 
LVMI-ht1.7 vs         
PWV            *   0.21 (0.12 to 0.29) <0.0001     0.05 (0.07 to 0.17)  =0.38 
        +MAP  0.16 (0.07 to 0.25) =0.0005     0.04 (-0.08 to 0.16) =0.50 
Aortic PP     *   0.17 (0.08 to 0.25) <0.0005     0.26 (0.14 to 0.37) <0.0001 
        +MAP  0.14 (0.05 to 0.22) <0.005     0.27 (0.15 to 0.38) <0.0001 
Aortic Pf      *   0.11 (0.01 to 0.19) <0.05     0.20 (0.08 to 0.31) <0.005 
        +MAP  0.05 (-0.04 to 0.14) =0.31     0.19 (0.07 to 0.30) <0.005 
Aortic Pb      *   0.15 (0.06 to 0.24)  =0.001     0.26 (0.15 to 0.37) <0.0001 
        +MAP  0.13 (0.04 to 0.22)  <0.01     0.27 (0.15 to 0.32) <0.0001 
_________________________________________________________________________ 
LVMI-ht1.7, left ventricular mass indexed to height1.7; LV stress, left ventricular systolic 
circumferential wall stress. See table 1 for additional abbreviations. *Adjustments are for MAP 
as indicated as well as age, body weight, pulse rate, regular smoking, regular alcohol intake, 
diabetes mellitus or an HbA1c>6.1% and treatment for hypertension.  
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was independently associated with LVMI in men, but not in women (Figure 3.2 and Table 3.2). 
With aortic Pb and Pf in the same regression models, Pb, but not Pf was independently 
associated with LVMI (Table 3.3) and the relationship between PPc and LVMI was attenuated 
with adjustments for Pb, but not Pf (data not shown). 
 
3.4 Relations between PWV or alternative aortic haemodynamic parameters and LVH. 
 
In multivariate adjusted models with either brachial SBP or PP (Figure 3.3) or mean 
arterial pressure (MAP) (Table 3.4) in the models, PPc and Pb, but not Pf were independently 
associated with LVH in both women and men. However, independent of brachial BP, PWV was 
associated with LVH in women, but not in men (Figure 3.3 and Table 3.4). Rt was not 
independently associated with LVH in either men or women (Figure 3.3 and Table 3.4). With 
aortic Pb and Pf in the same regression model, Pb, but not Pf was independently associated 
with LVH and the relationship between PPc and LVH was attenuated with adjustments for Pb, 
but not Pf (Table 3.5). 
 
3.5 Relations between PWV and LVMI or LVH are not explained by aortic BP. 
 
With adjustments for either PPc, Pf, or Pb in multivariate regression models, relations 
between aortic PWV and either LVMI or LVH in women were unchanged (Figure 3.4). 
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Table 3.3. Relations between aortic forward (Pf) or backward (Pb) wave pressures (in the same 
regression model) and left ventricular mass index (LVMI). 
 
Models Adjustors              Women (n=478)                           Men (n=271) 
                                                Partial r               p-value          Partial r              p-value  
_____________________________________________________________________  
LVMI-ht1.7 vs                              (95% CI)           (95% CI) 
 1)      Pb   * + brachial SBP    0.12 (0.03 to 0.21)     <0.05     0.19 (0.07 to 0.31)  <0.005 
          Pf                0.05 (-0.05 to 0.14)    =0.33     0.07 (-0.05 to 0.19) =0.27 
2)   Pb   * + brachial PP  0.10 (0.01 to 0.19)     <0.05     0.12 (0.002 to 0.24)  <0.05 
  Pf                         0.02 (-0.08 to 0.11)    =0.73     0.04 (-0.09 to 0.16) =0.57 
________________________________________________________________________ 
*Adjustments are for BP as indicated as well as age, body weight, pulse rate, regular smoking, 
regular alcohol intake, diabetes mellitus or an HbA1c>6.1% and treatment for hypertension. 
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Figure 3.3. Brachial systolic blood pressure (SBP) or pulse pressure (PP) adjusted relations 
between aortic haemodynamic parameters and left ventricular hypertrophy (LVH) in women 
(n=273 of 478) and men (n=60 of 271) of a community sample of African ancestry. See table 1 
for additional abbreviations. *Adjustments are for haemodynamic parameter as stated as well as 
age, body weight, pulse rate, regular smoking, regular alcohol intake, diabetes mellitus or an 
HbA1c>6.1% and treatment for hypertension. 
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Table 3.4 Relations between aortic haemodynamic parameters and left ventricular hypertrophy 
(LVH) before and after adjustments for mean arterial pressure (MAP) (steady-state pressure). 
 
                  Women (n=273 of 478)               Men (n=60 of 271)          
      Adjustors      OR (95% CI)          p-value      OR (95% CI)           p-value 
_________________________________________________________________________ 
LVH versus 
PWV            *          1.171 (1.051 to 1.305)  <0.005    1.139 (0.993 to 1.306) =0.06 
        +MAP         1.122 (1.002 to 1.256)  <0.05    1.135 (0.987 to 1.305) =0.08 
Aortic PP     *          1.029 (1.010 to 1.049)  <0.005    1.031 (1.006 to 1.057) <0.05 
        +MAP         1.026 (1.002 to 1.050)  <0.05    1.037 (1.007 to 1.068) <0.05 
Aortic Pf      *          1.041 (1.012 to 1.070)  <0.01    1.043 (1.002 to 1.085) <0.05 
        +MAP         1.027 (0.997 to 1.057)  =0.07    1.045 (1.000 to 1.093) =0.05 
Aortic Pb      *          1.055 (1.018 to 1.094)  <0.005    1.051 (1.006 to 1.098) <0.05         
        +MAP         1.064 (1.014 to 1.115)  =0.01    1.059 (1.004 to 1.117) <0.05 
_________________________________________________________________________ 
OR, odds ratios. LV stress, left ventricular systolic wall stress. See table 1 for additional 
abbreviations. *Adjustors are for MAP as indicated as well as age, body weight, pulse rate, 
regular smoking, regular alcohol intake, diabetes mellitus or an HbA1c>6.1% and treatment for 
hypertension. 
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Table 3.5. Relations between aortic forward (Pf) or backward (Pb) wave pressures (in the same 
regression model) and left ventricular hypertrophy (LVH). 
 
Models Adjustors              Women (n=478)                           Men (n=271) 
LVH vs                OR (95% CI)              p-value      OR (95% CI)             p-value 
_________________________________________________________________________ 
1)      Pb   * + brachial SBP  1.060 (1.005 to 1.118) <0.05       1.068 (0.984 to 1.159)  =0.11    
Pf               0.990 (0.958 to 1.022) =0.53       1.003 (0.933 to 1.079)  =0.93      
2)      Pb   * + brachial PP  1.062 (1.001 to 1.127) <0.05       1.077 (0.984 to 1.179)  =0.11    
Pf     0.989 (0.951 to 1.028) =0.58       1.024 (0.957 to 1.097)  =0.49    
OR, odds ratios. *Adjustors are for BP as indicated as well as age, body weight, pulse 
rate, regular smoking, regular alcohol intake, diabetes mellitus or an HbA1c>6.1% and 
treatment for hypertension. 
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Figure 3.4. Relations between aortic pulse wave velocity (PWV) and left ventricular mass 
indexed to height1.7 (LVMI) or LV hypertrophy (LVH) (n=273 of 478) before and after 
adjustments for alternative aortic haemodynamic parameters in women of a community sample 
of African ancestry. See table 1 for additional abbreviations. *Adjustments are for hemodynamic 
parameter a stated as well as age, body weight, pulse rate, regular smoking, regular alcohol 
intake, diabetes mellitus or an HbA1c>6.1% and treatment for hypertension. 
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4.1 Summary of main findings. 
 
The main findings of the present study are as follows: In a relatively large, randomly 
selected community sample of African ancestry, aortic (carotid-femoral) PWV was 
independently associated with LVMI and LVH in women, but not in men. However, this 
relationship in women persisted with adjustments for aortic PP and forward wave pressures. 
Moreover, this occurred despite the fact that aortic PP and backward wave pressures were also 
independently associated with LVMI and LVH in both women and in men and the relationships 
between either PWV or aortic BP and LVMI or LVH, although noted to occur together, were 
independent of each other. 
 
4.2 Comparison with previous studies 
 
As summarized in section 1.4.3 of chapter 1, many studies have shown that indices of 
arterial stiffness are associated with LVM (Baguet et al., 2000;  Bell et al., 2015;  Bouthier et al., 
1985;  Boutouyrie et al., 1995;  Chen et al., 1998;  Deague et al., 2001;  Gates et al., 2003;  
Iketani et al., 2000;  Kobayashi et al., 1996;  Leoncini et al., 2006;  Libhaber et al., 2008;  
Ohyama et al., 2016;  Roman et al., 2000;  Roman et al., 1996;  Tatchum-Talom et al., 1995). In 
this regard three human studies suggest that arterial stiffness effects on LVM are independent 
of brachial artery BP (Lekakis et al., 2004;  Leoncini et al., 2006;  Libhaber et al., 2008). Of 
these studies, one was conducted in a very small study sample (Lekakis et al., 2004)  (n=48), 
another was a study relating the less well recognized ambulatory arterial stiffness index with 
LVM (Leoncini et al., 2006) (the extent to which the information derived from the ambulatory 
arterial stiffness index is comparable with that of pulse wave analysis is uncertain as the 
correlation coefficient between the two is ~0.5) (Li et al., 2006), but the third, performed by our 
group, showed strong independent relations between aortic PWV and LVM in women, but not in 
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men in a larger study sample (Libhaber et al., 2008). These data were however described in a 
smaller study sample of men (n=123 as compared to the 271 men studied in the present 
analysis), and hence the lack of ability of aortic PWV to relate to LVMI independent of brachial 
BP in men could have been attributed to the fact that this study was underpowered to show 
such an effect (Libhaber et al., 2008). However, the present study confirms these findings in a 
much larger study sample of both women (478 versus 204) and of men. Nevertheless, a number 
of studies have failed to demonstrate brachial BP or mean arterial pressure-independent 
relations between PWV and LVMI or on-treatment decreases in LVMI (Chen et al., 1998; 
Coutinho et al., 2016; Hashimoto et al., 2008a; Hashimoto et al., 2008b; Kaess et al., 2016), 
even when sex-specific relations were evaluated (Coutinho et al., 2016). Whether differences 
between the present and these prior studies can be attributed to several of these studies 
employing small samples of hypertensives (Baguet et al., 2000; Bouthier et al., 1985), where a 
narrow range of BP values only encompassing the upper tail of the distribution in the population 
at large might have reduced the power to detect an independent association between LVM 
index and PWV, is unclear. Differences between studies may also be attributed to differences in 
the demographic or clinical profiles of the different studies or to differences in measurement 
techniques several studies employed measurements other than PWV (Chen et al., 1998; 
Roman et al., 2000; Roman et al., 1996). Importantly however, the present study showed robust 
probability values for such relations in women and hence is unlikely to reflect a false positive 
finding. Moreover, because none of the previous large studies could show a relation between 
measures of aortic stiffness and LVM independent of brachial BP, the present study is the only 
study where the potential mechanism of this relationship could be evaluated. What are the 
implications of the findings of the present study?   
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4.3 Possible implications of the present study 
 
Although aortic PWV is an independent predictor of cardiovascular events (Ben-Shlomo 
et al., 2014; Vlachopoulos et al., 2010) the extent to which this relationship is explained by an 
impact of aortic stiffness on aortic PP, associated forward or reflected wave changes is 
uncertain. Although as indicated above, some studies have shown that the relations between 
aortic PWV and LVM are independent of brachial BP (Lekakis et al., 2004;  Libhaber et al., 
2008), none of these prior studies have explored whether these associations are explained by 
aortic BP effects. Indeed, as indicated in chapter 1, section 1.4.3, aortic PWV could produce 
increases in LVMI beyond brachial BP through an increased reflected wave amplitude or an 
wave time (by increasing the speed of wave reflection and by generating closer inflection points) 
and hence producing a greater aortic systolic PP augmentation (and thus aortic PP and systolic 
BP), which once again may not be adequately indexed by brachial PP. However, the results of 
the present study indicate that the brachial-BP independent relationship between aortic PWV 
and LVMI is not explained by increases in the aortic forward wave pressures, backward wave 
pressures, and hence increases in aortic PP, systolic BP. 
The present results may explain some of the conflicting evidence on relations between 
aortic PWV and LVMI (Booysen et al., 2015; Hashimoto and Ito, 2011; Sibiya et al., 2015; Tade 
et al., 2017; Westerhof et al., 2006; Zamani et al., 2015). The present study suggests that any 
relations which do exist, may not be through alterations in resting aortic forward or backward 
wave pressures and hence aortic PP. However, these results must be interpreted in context. 
These results do not suggest that an impedance mismatch mediated by proximal aortic 
stiffness (as opposed to stiffness along the whole length of the aorta) may not be causally 
related to increases in LVMI or LVH beyond central aortic pressures as previously 
demonstrated (Hashimoto and Ito, 2011; Zamani et al., 2015). Moreover, these results do not 
exclude the possibility of total arterial compliance (reservoir function) significantly influencing 
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LVMI or LVH as also recently shown (Zamani et al., 2015). In addition, aortic PWV may 
produce an earlier return of the reflected wave and subsequently enhance LV load during the 
systolic period of the cardiac cycle. This may be particularly important in women who have a 
shorter stature and hence have a shorter reflected wave travel distance, thus explaining the 
relations in women, but not men in the present study. As the assessment of the reflected wave 
time derived from the ‘triangular flow wave’ approach to wave separation analysis is inaccurate 
(Kips et al., 2009) and simultaneous flow and pressure measurements are required for an 
accurate evaluation (Phan et al., 2016), we could not accurately assess the speed (or timing) of 
wave reflection. Furthermore, the present results do not exclude the possibility that physical 
activity-related increases in forward wave and hence PP and systolic BP may be exacerbated 
by increases in aortic PWV and that these may contribute to LVMI or LVH. In this regard, 
further work is required to evaluate whether PWV enhances activity-related increases in aortic 
BP and that these effects contribute to increases in LVM. 
Although the present study suggests that brachial BP–independent relations of aortic 
(carotid-femoral) PWV with LVMI may not be through an impact on resting aortic forward and 
backward wave pressures and hence aortic PP. Although the role of aortic PWV as a predictor 
of heart failure has not been adequately addressed (Ben-Shlomo et al., 2014;  Vlachopoulos et 
al., 2010), aortic PWV in some (Coutinho et al., 2016), but not other (Peterson et al., 2016) 
studies may independently associate with a reduced LV diastolic function, a relationship which 
may translate into the development of heart failure with a preserved ejection fraction beyond 
brachial BP. Moreover, increases in aortic stiffness may produce adverse effects on the 
coronary circulation (Ikonomidis et al., 2008;  Watanabe et al., 1993). Whether this explains the 
predictive power beyond brachial BP of aortic PWV for coronary events which normally involve 
plaque rupture (Ben-Shlomo et al., 2014;  Vlachopoulos et al., 2010), is nevertheless unknown. 
Based on the present analysis it is possible that aortic PWV predicts coronary events 
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independent of brachial BP rather because it is an excellent index of long-term cardiovascular 
damage that is largely insensitive to the benefits of antihypertensive therapy. 
There are further caveats to the interpretation of the results of the present study. A lack 
of brachial BP-independent relationship between aortic PWV and LVMI that cannot be explained 
by aortic pressure effects, does not imply that a portion of the aortic PWV-LVMI relationship 
cannot be explained by pulsatile haemodynamic effects which are readily detected at the 
brachial artery. Indeed, the strength of aortic PWV versus LVMI relations is reduced when 
adjusting for brachial PP. Because of the strong relationship that exists between brachial PP 
and either aortic PP, or forward wave pressures, one assumes that this means that aortic PWV-
induced increases in forward wave pressure and aortic PP contribute to much of the brachial 
PP-LVMI relation. 
 
4.4 Are there aortic pressure effects on LVMI beyond brachial BP? 
 
 The lack of ability of aortic PP to explain brachial BP-independent relationships between 
aortic PWV and LVMI or LVH does not exclude the possible importance of aortic BP as a 
determinant of LVMI beyond brachial BP. Importantly, consistent with several publications in the 
present study population (Booysen et al., 2015;  Norton et al., 2012; Sibiya et al., 2015), and 
with the findings of several other groups recently summarized in a review (Roman et al., 2007)  
and a meta-analysis (Ben-Shlomo et al., 2014), the present study shows consistent brachial BP-
independent relations between aortic BP and LVMI or LVH. As with previous reports (Sibiya et 
al., 2015), these findings are explained by the brachial BP- independent relationship between 
aortic backward, but not forward wave pressure and LVMI or LVH. Hence, the present study 
also suggests that aortic backward wave effects on end-organ measures should not be seen as 
representing an impact of aortic stiffness. Indeed, although aortic backward wave pressures 
contribute substantially to variations in aortic PP and LVMI (Booysen et al., 2015), these effects 
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are independent of aortic PWV (present study). In this regard, it is important to note that the 
direct relations between backward wave pressures and aortic PWV that have been described 
(Sibiya et al., 2015) are likely to be explained by reverse causality. That is, increases in 
backward wave magnitude cause damage to the aorta and this increases aortic stiffness, rather 
than increases in aortic stiffness cause an increase in aortic backward wave magnitude. Indeed, 
it has been argued that once aortic stiffness begins to increase dramatically with age it reduces 
the impedance mismatch between the aorta and large vessels which reduces wave reflection 
(Mitchell et al., 2010). 
 
4.5 Possible limitations of the present study 
 
As the assessment of the reflected wave time derived from the ‘triangular flow wave’ 
approach to wave separation analysis may be inaccurate (Kaess et al., 2016) and simultaneous 
flow and pressure measurements are required for an accurate evaluation (Peterson et al., 
2016), it could be argued that I cannot exclude a possible contribution of the timing of wave 
reflection to PWV-LVMI relations. However, the contribution of an earlier time of wave reflection 
to PWV-LVM relations would be explained by an enhanced aortic PP. As variations in aortic PP 
did not explain PWV-LVM relations, I assume that the time to wave reflection plays little role in 
mediating these relations. In addition, the use of the ‘triangulation method’ of aortic wave 
separation to derive aortic forward and backward wave pressures has also been questioned 
(Kaess et al., 2016). However, as emphasized in the methods section, our group have 
previously shown similar relations between Pf or Pb and LVMI when Pb or Pf were derived from 
wave separation analysis employing actual flow measurements versus Pb or Pf derived from 
the triangular waveform approach to wave separation analysis (Bell et al., 2015). Hence, at 
least in the present study, the use of the ‘triangulation method’ to derive backward and forward 
wave pressures is unlikely to have significantly affected the results.   
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There are several additional possible limitations to the present study that warrant 
consideration. First, in the present study, calibration of the radial waveform from brachial BP 
measurements ignores amplification of BP from brachial to radial arteries (Watanabe et al., 
1993). Hence, aortic pressures are likely to have been underestimated using the current 
approach. However, both forward and backward wave pressures would have been affected by 
this calibration error and aortic backward, but not forward wave pressures were independently 
associated with LVMI and LVH. Second, the present study was conducted in one ethnic group 
and more women than men participated. The present findings may therefore be sex-specific 
and may not be translatable to other ethnic groups. 
 
4.6 Conclusions 
 
In conclusion, in the present study I show, in a relatively large randomly selected 
community sample that carotid-femoral PWV is associated with LVMI and LVH in women, but 
not in men and that these relations in women are independent of brachial PP and systolic BP. 
However, these relations between aortic PWV and LVMI or LVH in women were not attributed 
to increases in aortic forward or backward wave pressures and hence to increases in aortic PP 
or LV load as determined under resting conditions. Nevertheless, in addition to aortic PWV 
being independently associated with LVMI and LVH, both aortic PP and backward wave 
pressures were independently associated with LVMI and LVH beyond brachial BP. These data 
provide further insights into the mechanisms that account for relationship between aortic PWV 
and cardiovascular risk. 
 
4.7 Potential clinical relevance 
 
The results of this study provide further knowledge on the relationship between aortic 
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pulse wave velocity and other aortic hemodynamic parameters and LVMI. In this regard, the 
data provide some mechanistic insights into the ability of aortic pulse wave velocity to 
independently predict cardiovascular events. As the associations of aortic pulse wave velocity 
and Pb (and hence pulse pressure) with LVMI and LVH produce effects which were 
independent of each other, aortic pulse wave velocity and backward waves are likely to have a 
differential impact on LVMI. These data may potentially guide clinical management strategies in 
the future in that both aortic pulse wave velocity and aortic backward waves need to be 
targeted in order to prevent the development of LVH in response to increased stiffness and 
high pulse pressures. 
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